Literature DB >> 9469573

Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra.

W Löscher1, U Ebert, H Lehmann, C Rosenthal, G Nikkhah.   

Abstract

Compared with studies on models of neurodegenerative diseases, considerably less work has been performed with neural grafts in experimental epilepsy. The potential value of this approach, however, is already shown by evidence that noradrenergic grafts implanted bilaterally into the hippocampus or amygdala-piriform cortex can suppress seizure development in the kindling model of temporal lobe epilepsy. We previously showed that amygdala kindling results in a significant decrease of GABA and its synthesizing enzyme glutamate decarboxylase in substantia nigra (SN), i.e., a region thought to be critically involved in seizure propagation in various models of epilepsy. Thus, transplantation of fetal GABAergic neurons into SN might be an effective means of permanently blocking seizure generalization in kindling epilepsy and probably also other types of epilepsy. To test this hypothesis, three groups of female Wistar rats (n = 10 per group) were kindled by electrical stimulation via a bipolar electrode in the basolateral amygdala. After all rats were fully kindled, one group was implanted with GABA-rich cells prepared from the striatal eminence of Wistar rat fetuses at embryonic day 14. The striatal neurons were bilaterally microinjected at various sites over the anterior-posterior axis of the SN, aimed at the pars reticulata. The second group received microinjections of spinal cord cell preparations, whereas the third group received microinjections of cell-free medium only. In all rats, the threshold for focal discharges (afterdischarge threshold [ADT]) as well as afterdischarge duration and severity and duration of seizures occurring at ADT current were determined once weekly before and after transplantation. Eleven to 12 weeks following transplantation, the rats were killed, and location and integration of grafts were examined by immunohistological methods. Rats with GABAergic grafts in SN exhibited a significant increase in ADT and marked reduction in seizure severity compared with pretransplantation values, whereas no such alteration was seen in the other groups. However, the seizure-suppressing effect of GABAergic grafts was not permanent but slowly disappeared over the weeks after transplantation. Although the data indicate that intranigral transplantation of GABA-producing cells is no effective means of inducing long-lasting anticonvulsant effects in experimental epilepsy, this approach may be an initial step to develop more efficient strategies for seizure suppression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469573     DOI: 10.1002/(SICI)1097-4547(19980115)51:2<196::AID-JNR8>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  35 in total

1.  Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy.

Authors:  Ben Waldau; Bharathi Hattiangady; Ramkumar Kuruba; Ashok K Shetty
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

Review 2.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

3.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 4.  Commentary: the prospect of cell-based therapy for epilepsy.

Authors:  Arnold R Kriegstein; Asla Pitkänen
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

5.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

6.  Neural stem cell grafting in an animal model of chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Ashok K Shetty
Journal:  Curr Protoc Stem Cell Biol       Date:  2011-09

7.  Descending projections from the substantia nigra pars reticulata differentially control seizures.

Authors:  Evan Wicker; Veronica C Beck; Colin Kulick-Soper; Catherine V Kulick-Soper; Safwan K Hyder; Carolina Campos-Rodriguez; Tahiyana Khan; Prosper N'Gouemo; Patrick A Forcelli
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 8.  GABA-ergic cell therapy for epilepsy: Advances, limitations and challenges.

Authors:  Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2015-12-31       Impact factor: 8.989

Review 9.  Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit.

Authors:  Steven C Schachter; John Guttag; Steven J Schiff; Donald L Schomer
Journal:  Epilepsy Behav       Date:  2009-09       Impact factor: 2.937

10.  Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice.

Authors:  Scott C Baraban; Derek G Southwell; Rosanne C Estrada; Daniel L Jones; Joy Y Sebe; Clara Alfaro-Cervello; Jose M García-Verdugo; John L R Rubenstein; Arturo Alvarez-Buylla
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.